The benefits, risks, and threats of biotechnology

Science and Public Policy

Volumn 35, Issue 1, 2008, Pages 37-43

  Rappert, Brian ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; POLICY ANALYSIS; RESEARCH; RISK ASSESSMENT; SECURITY THREAT;

EID: 42549154292     PISSN: 03023427     EISSN: None     Source Type: Journal    
DOI: 10.3152/030234207X276509     Document Type: Article

References (31)

1. Baker, S and J Kaprio 2005 Common susceptibility genes for cancer. British Medical Journal, 332, 15 March, 1150-1152.
2. Boudeau, C 2007 Producing threat assessments. In Technology and Security, ed. B Rappert. London: Palgrave.
3. Brannigan, A 1981 The Social Basis of Scientific Discoveries. Cambridge: Cambridge University Press.
4. Cello, C, A Paul and E Wimmer 2002 Chemical synthesis of poliovirus cDNA. Science, 297, 1016-1018.
5. Davidson, E M, R Frothingham and R Cook-Deegan 2007 Practical experiences in dual-use review. Science, 316, 8 June, 1432-1433.
6. European Commission 2007 Personal communication to author. Reference Number: 3494133, 26 January.
7. Fink, G 2003 Preface. In Biotechnology Research in an Age of Terrorism, eds. National Research Council. Washington, DC: NRC.
8. Gilbert, N and M Mulkay 1984 Opening Pandora's Box. Cambridge: Cambridge University Press.
9. Harremonds, P et al 2002 The Precautionary Principle. London: Earthscan.
10. Harris, E 2007 Dual-use biotechnology research. In A Web of Prevention, eds. B Rappert and C McLeish. London: Earthscan.
11. Holohan, T 2007 Reflections on the role of research oversight in a web of prevention. In A Web of Prevention, eds. B Rappert and C McLeish. London: Earthscan.
12. Institute of Medicine and National Research Council 2006 Globalization, Biosecurity, and the Future of the Life Sciences. Washington, DC: IoM and NRC.
13. Jackson, R, A Ramsay, C Christensen, S Beaton, D Hall and I Ramshaw 2001 Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. Journal of Virology, 75(3), 1205-1210.
14. Johnson, D 1999 Reframing the question of forbidden knowledge for modern science. Science and Engineering Ethics, 5(4), 445-461.
15. Journal Editors and Authors Group 2003. PNAS, 100(4), 1464.
16. McLeish, C and P Nightingale 2005 Effective Action to Strengthen the BTWC Regime. Bradford Briefing Paper No. 17, May. Available at , last accessed 20 September 2007.
17. Miller, L 2006 Publishing and Biosecurity. Presentation to Dual Use and Codes of Conduct Meeting, 2 December, Berlin.
18. NRC, National Research Council 2003 Biotechnology Research in an Age of Terrorism. Washington, DC: National Academy of Sciences.
19. NRC, National Research Council 2004 Seeking Security: Pathogens, Open Access and Genome Databases. Washington, DC: National Academy of Sciences.
20. NRC, National Research Council 2006 Globalization, Biosecurity, and the Future of the Life Sciences Washington, DC: National Academy of Sciences.
21. Rappert, B 2007a Biotechnology, Security and the Search for Limits. London: Palgrave.
22. Rappert, B 2007b Education for the life sciences. In A Web of Prevention, eds. B Rappert and C McLeish. London: Earthscan.
23. Rappert, B, M Chevrier and M Dando 2006 In-Depth Implementation of the BTWC. Bradford Review Conference Paper No. 18. Available at , last accessed 20 September 2007.
24. Rollin, B 2006 Science and Ethics. Cambridge: Cambridge University Press.
25. Royal Society 2007 Science and technology developments relevant to the biological and toxin weapons convention. In A Web of Prevention, eds. B Rappert and C McLeish. London: Earthscan.
26. Sarewitz, D 1996 Frontiers of Illusion. Philadelphia: Temple University Press.
27. Shenk, T 2003 Sensitive Research. Presented at Meeting on National Security and Research in the Life Sciences National Academies and the Center for Strategic and International Studies, 9 January, Washington, DC.
28. Taubenberger, J K, A H Reid, R M Lourens et al 2005 Characterization of the 1918 influenza virus polymerase genes. Nature, 437, 6 October, 889-893.
29. Terry, R 2006 Addressing Risks of Research Misuse. Presentation to Dual Use and Codes of Conduct Meeting, 2 December, Berlin.
30. Tumpey, T M, C F Basler, P C Aguilar et al 2005 Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science, 310(5745), 7 October, 77-80.
31. Van Aken, J 2006 When risks outweigh benefits. EMBO Reports, 7, S10-13. Available at , last accessed 20 September 2007.